CD36 defines primitive chronic myeloid leukemia cells less responsive to imatinib but vulnerable to antibody-based therapeutic targeting.
about
CD36 defines primitive chronic myeloid leukemia cells less responsive to imatinib but vulnerable to antibody-based therapeutic targeting.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
CD36 defines primitive chronic ...... y-based therapeutic targeting.
@en
CD36 defines primitive chronic ...... y-based therapeutic targeting.
@nl
type
label
CD36 defines primitive chronic ...... y-based therapeutic targeting.
@en
CD36 defines primitive chronic ...... y-based therapeutic targeting.
@nl
prefLabel
CD36 defines primitive chronic ...... y-based therapeutic targeting.
@en
CD36 defines primitive chronic ...... y-based therapeutic targeting.
@nl
P2093
P2860
P50
P1433
P1476
CD36 defines primitive chronic ...... dy-based therapeutic targeting
@en
P2093
Carl Sandén
Helena Ågerstam
Henrik Hjorth-Hansen
Johan Richter
Maria Askmyr
Marianne Rissler
Sofia von Palffy
Thoas Fioretos
P2860
P304
P356
10.3324/HAEMATOL.2017.169946
P577
2017-12-28T00:00:00Z